{
"id":"vdx4_gm_q017",
"number":17,
"bookId":"vdx_gm",
"correctAnswer":"C",
"title":"Question 17",
"stimulus":[
{
"type":"p",
"hlId":"54c5d7",
"children":[
"A patient is evaluated for a skin condition that reappears at the same location each time the patient is exposed to a sulfa-containing drug. The patient's posterior neck is ",
{
"type":"figure-link",
"target":"vdx4_gm_mcq_f017",
"wrapId":"1",
"children":[
"shown"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"vdx4_gm_mcq_f017"
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"413696",
"children":[
"Which of the following is the most likely diagnosis?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Angioedema"
}
},
{
"letter":"B",
"text":{
"__html":"Erythema multiforme"
}
},
{
"letter":"C",
"text":{
"__html":"Fixed drug eruption"
}
},
{
"letter":"D",
"text":{
"__html":"Urticaria"
}
}
],
"exposition":[
{
"type":"p",
"hlId":"504d3c",
"children":[
"This patient's skin finding is most compatible with a fixed drug eruption, in which one or more erythematous or violaceous annular lesions recur in the same location(s) with each re-exposure to the offending drug. The lesions resolve with hyperpigmentation."
]
}
],
"relatedSection":"mk19_b_gm_s10_5_2",
"objective":{
"__html":"Diagnose a fixed drug eruption."
},
"references":[

],
"hospitalist":false,
"hvc":false,
"peerComparison":{
},
"figuresContent":{
"vdx4_gm_mcq_f017":{
"id":"vdx4_gm_mcq_f017",
"number":17,
"bookId":"vdx_gm",
"legend":"",
"footnotes":[

],
"imageInfo":{
"hash":"c2d6a089abea4019d4a3f92a5f7d06da",
"height":966,
"width":786,
"extension":"jpg"
}
}
},
"hlIds":[
"54c5d7",
"413696",
"504d3c"
]
}